Department of Medicine
Faculty Profiles by Division

Department of Medicine

Faculty Profiles

[Return To Index page]
photo Taofeek K. Owonikoko, MD, PhD

Hematology/Oncology

Professor of Medicine, Division of Hematology-Oncology

Division Chief, Division of Hematology-Oncology

Associate Director for Translational Research, UPMC Hillman Cancer Center

Co-Leader, Cancer Therapeutics Program, UPMC Hillman Cancer Center

Email: owonikokotk2@upmc.edu

Phone: 412-623-5898

Contact
Office: 5150 Centre Avenue, Room 571
UPMC Cancer Pavilion
Pittsburgh, PA 15232
 
Phone: 412-623-5898
Fax: 412-648-6579
E-mail: owonikokotk2@upmc.edu
Administrative Assistant:
Alice A. Petrovich
Address: 5150 Centre Avenue
UPMC Cancer Pavilion, Suite 5C
Pittsburgh, PA, PA 15232
Email: petrovichaa2@upmc.edu
Phone: 412-648-6589
Fax: 412-648-6579
Education and Training
Education
MD, Obafemi Awolowo University, Ile-Ife Nigeria, 1991
PhD, Heinrich Heine University, Dusseldorf, Germany, 2000
MS, Clinical Research, Emory University, Atlanta, GA, 2014
Training
Intern, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria, 1992
Resident, Anatomic Pathology, Lagos University Teaching Hospital, Lagos, Nigeria, 1998
Postdoctoral Research Fellow, Johns Hopkins University, Baltimore, MD, 2002
Resident, Internal Medicine, Graduate Hospital, Drexel University, Philadelphia, PA, 2005
Fellow, Hematology & Medical Oncology, UPMC, Pittsburgh, PA, 2008
Research Interest
His research interests are in pre-clinical biomarker discovery in lung cancer and other solid tumor types, and translation of promising laboratory findings into clinical trials in collaboration with academic and industry partners. He has received extramural grant funding in support of his laboratory and translational research from the National Institutes of Health, Department of Defense and private foundations.
Clinical Interest
Dr. Owonikoko is a physician-scientist, board-certified in Medical Oncology, Hematology and Internal Medicine with a clinical focus on treating patients with lung cancer.